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Human calcitonin (hCT), composed of 32 amino acids, was discovered to be a calcium-lowering hormone (Copp et al., 1962) . Kidney is known to be one of the most important target organs of hCT, and to have a specific receptor for this hormone (Ardaillou, 1975) . However, little is known about the concentration or immunological properties of calcitonin (CT) excreted from the kidney in the urine. The present study was designed to establish a technique for measuring urinary CT, and to investigate the size-heterogeneity of CT in the urine. et al. Materials Synthetic (1-32)hCT, [Asu1,7]-hCT, and synthetic peptide fragments (11-32)hCT (17-32)hCT and (21-32)hCT were kindly supplied by Dr. S. Sakakibara, Peptide Institute, Protein Research Foundation, Osaka, Japan. Ammonium bicarbonate, ammonium acetate, urea, creatinine, creatine, caffeine, theophylline, theobromine, guanosine, thymidine, DNA, proline and histidine were obtained from Wako Pure Chemical Industries, Ltd., Osaka, Japan. Blue dextran (B-2000, 2,000,000 daltons) and bovine serum albumin were obtained from Sigma Chemical Company, St. Louis, Mo, U.S.A. Bio Gel P-2 (100-200 mesh) and Bio Gel P-30 (100-200 mesh) were obtained from Bio-Rad Laboratories, Richmond, Cal, U.S.A. Bovine parathyroid hormone (bPTH) was obtained from Inorex Co. Ltd., Ill, U.S.A. Synthetic (1-32)hCT for infusion (CIBACALCIN(R)) was kindly supplied by Ciba-Geigy Co. Ltd., Basel, Switzerland.
Experimental Procedure
Determination of plasma CT concentration: Plasma hCT concentrations were determined by RIA. 
Results
Specificity of Antiserum for hCT RIA Figure 2 shows the inhibition of binding of produced by the addition of synthetic (1-32) hCT or its synthetic peptide fragments. The concentrations of [Asu1,7]-hCT, the (11-32) hCT fragment and the (17-32)hCT fragment required for 50% inhibition of tracer bindind to the antiserum were almost equimolar with that of intact (1-32)hCT. However, about 7.6 times more (21-32)hCT fragment than (1-32)hCT was required to produce 50% inhibition with this antiserum. Consequently the antiserum used for RIA appeared to have a major antigenic site within residues 17-20 of (1-32)hCT and a minor antigenic site within residues 21-32.
Interference with hCT RIA by Various Kinds of Compounds
The degrees of interference with hCT RIA by blue dextran and by a series of known constituents of the urine are shown in Fig.  3 .
Blue dextrane, creatine, proline and histidine did not interfere with hCT RIA. However, guanosine, DNA, theophylline, thymidine, caffeine, creatine and urea caused interference.
Recovery, Reproducibility and Dilution Curves in Urinary Determination of CT.
Seven samples of saline with and without synthetic (1-32)hCT added at concentrations of 100, 400, 800 and 1600pg/ml were gelfiltrated on a Bio Gel P-2 column and assayed for hCT. The hCT levels of the 7 samples Blue dextarn, creatine, proline and histidine did not cause interference.
Many constituents of urine, however, and analogues interferred with the RIA system, and the dilution curves of these compounds were not parallel with the standard curve.
without added synthetic (1-32)hCT were all below the detection limit. The degrees of recovery of hCT after filtration on a Bio Gel P-2 column of samples containing synthetic (1-32)hCT at concentrations of 100, 400, (Fig.  4) . Fig. 5 . Plasma hCT levels and urinary CT levels of 11 patients with MCT. These two levels were positively correlated (r=0.93, P<0.001) and CT levels in the urine (in ng/mg Cr) were 3.4 to 20.8times higher than those in the plasma (in ng/ml). mg/ml (r=0.682, P<0.001), and with urinary urea levels in mg/ml (r=0.754, P<0.001).
The levels of urinary CT after gel filtration in pg/mg Cr, were not correlated significantly with the urinary creatinine levels (r=0.079, P>0.1), or with the urinary urea levels (r= Fig. 6 . The plasma hCT levels and urinary CT levels of 32 normal subjects. These two levels were positively correlated (r=0.408, P<0.05). Fig. 7 . The CT levels of spot urine samples in the morning and those of 24 hr urine from 20 normal subjects. These two levels were positively correlated (r=0.650, P<0.005). Changes in hCT Levels in Plasma and Urine of Normal Subjects on Infusion of Synthetic (1-32)hCT (Fig. 8, b ).
In the three normal subjects tested, the plasma hCT levels rose from basal levels of 0.100, 0.047 and 0.042mg/ml to maximum levels of 120, 72 and 53mg/ml, respectively, after the starting of infusion, and then dropped with apparent half-times of 6.5, 7.0 and 8.0 min, respectively, in 30min after the infusion. The levels of CT excreted in the urine in 15 min rose from basal levels of 2.7, 1.9 and 1.5 ng/15min to maximum levels of 225, 138 and 149ng/15min, respectively, in the first 15min after the infusion, and then dropped (or fell) with apparent half-times of 27, 34 and 20min.
The total CT immunoreactivities
